SEC61B and neoplasm: The anti-tumor response to the combination of curcumin and OPCs in mice xenograft tumors and organoids derived from primary human CRC tumors correlated with the altered gene expressions of HSPA5, IHH, PDE3B, cyclin D1 and SEC61B.